A longitudinal assessment of aflatoxin M1 excretion in breast milk of selected Egyptian mothers

Food and Chemical Toxicology

Volumn 45, Issue 7, 2007, Pages 1210-1215

  Polychronaki, Nektaria ^a   West, Robert M ^b   Turner, Paul C ^c   Amra, Hassan ^d   Abdel Wahhab, Mossad ^d   Mykkänen, Hannu ^a   El Nezami, Hani ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Aflatoxin M1; Breast milk; Egypt; Seasonality

Indexed keywords

AFLATOXIN M1; CARCINOGEN;

ARTICLE; BREAST FEEDING; BREAST MILK; EGYPT; EXCRETION; FEMALE; HUMAN; INFANT; LACTATION; LONGITUDINAL STUDY; NORMAL HUMAN; PEANUT; SAMPLING; SEASONAL VARIATION; SUMMER; WINTER;

ADOLESCENT; ADULT; AFLATOXIN M1; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EGYPT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; FOOD CONTAMINATION; HUMANS; INFANT; LOGISTIC MODELS; LONGITUDINAL STUDIES; MILK, HUMAN; POISONS; TIME FACTORS;

ARACHIS HYPOGAEA;

EID: 34247185942     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.01.001     Document Type: Article

References (37)

1. Allen S.J., Wild C.P., Wheeler J.G., Riley E.M., Montesano R., Bennett S., Whittle H.C., Hall A.J., and Greenwood B.M. Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans. R Soc., Trop. Med. Hyg. 86 (1992) 426-430
2. Angelico M., Renganathan E., Gandin C., Fathy M., Profili M.C., Refai W., De Santis A., Nagi A., Amin G., Capocaccia L., et al. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J. Hepatol. 26 (1997) 236-243
3. AOAC. Aflatoxins M1 and M2 in fluid milk. In: Scott P.M. (Ed). Natural Toxins (1995), Association of Official Analytical Chemists, Arlington, VA 34-35
4. Attia M.A. Prevalence of hepatitis B and C in Egypt and Africa. Antivir. Ther. 3 (1998) 1-9
5. Barker D.J. The developmental origins of chronic adult disease. Acta Paediatr. Suppl. 93 (2004) 26-33
6. Clewell R.A., and Gearhart J.M. Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure. Environ. Health Perspect. 110 (2002) A333-A337
7. Delisle H. Foetal programming of nutrition-related chronic diseases. Sante 12 (2002) 56-63
8. El-Nezami H., Nicoletti G., Neal G.E., Donohue D.C., and Ahokas J.T. Aflatoxin M1 in human breast milk samples from Victoria, Australia and Thailand. Food Chem. Toxicol. 33 (1995) 173-179
9. El-Nezami H., Mykkänen H., Kankaanpaa P., Suomalainen T., Salminen S., and Ahokas J. Ability of a mixture of lactobacillus and propionibacterium to influence the faecal aflatoxin content in healthy Egyptian volunteers: a pilot clinical study. Bioscience. Microflora. 19 (2000) 41-45
10. El-Shewey, E.A., 1987. Some Toxicological Studies on contaminated breast milk by aflatoxins (Ph.D thesis). Zagazig University, Benha Branch, Egypt, p. 170.
11. El-Zayadi A.R., Badran H.M., Barakat E.M., Attia Mel D., Shawky S., Mohamed M.K., Selim O., and Saeid A. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J. Gastroenterol. 11 (2005) 5193-5198
12. Firestone M.P., and Amler R.W. Children's environmental health-an international perspective. Int. J. Hyg. Environ. Health 206 (2003) 395-400
13. Gong Y., Cardwell K., Hounsa A., Egal S., Turner P.C., Hall A.J., and Wild C.P. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ 325 (2002) 20-21
14. Gong Y., Hounsa A., Egal S., Turner P.C., Sutcliffe A.E., Hall A.J., Cardwell K., and Wild C.P. Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ. Health Perspect. 112 (2004) 1334-1338
15. Hifnawy M.S., Mangoud A.M., Eissa M.H., Nor Edin E., Mostafa Y., Abouel-Magd Y., Sabee E.I., Amin I., Ismail A., Morsy T.A., et al. The role of aflatoxin-contaminated food materials and HCV in developing hepatocellular carcinoma in Al-Sharkia Governorate, Egypt. J. Egypt Soc. Parasitol. 34 (2004) 479-488
16. IARC. 1993. Some naturally occurring substances - food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monogr Eval Carcinog Risk Hum, Lyon, France, 56, pp. 245-391.
17. IARC. 2002. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr Eval Carcinog Risk Hum,.Lyon, France, pp. 1-556.
18. Kuiper-Goodman T. Approaches to the risk assessment of mycotoxins in foods: aflatoxins. In: Bray G.A., and Ryan D.H. (Eds). Myotoxins, Cancer and Health (1991), Louisiana State University Press 352
19. Landrigan P.J., Sonawane B., Mattison D., McCally M., and Garg A. Chemical contaminants in breast milk and their impacts on children's health: an overview. Environ. Health Perspect. 110 (2002) A313-A315
20. Polychronaki N., Turner P.C., Mykkanen H., Gong Y., Amra H., Abdel-Wahhab M., and El-Nezami H. Determinants of AFM1 in breast milk in a selected group of Egyptian mothers. Food Addit. Contam. 23 (2006) 700-708
21. Pronczuk J., Moy G., and Vallenas C. Breast milk: an optimal food. Environ. Health Perspect. 112 (2004) 722-723
22. Saeed A.A., Al-Admawi A.M., Al-Rasheed A., Fairclough D., Bacchus R., Ring C., and Garson J. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 338 (1991) 459-460
23. Selim M.I., Popendorf W., Ibrahim M.S., El-Sharkawy S., and El-Kashory E.S. Aflatoxin B1 in common Egyptian foods. J. AOAC Int. 79 (1996) 1124-1129
24. Solomon G.M., and Weiss P.M. Chemical contaminants in breast milk: time trends and regional variability. Environ. Health Perspect. 110 (2002) A339-A347
25. Sylla A., Diallo M.S., Castegnaro J.W., and Wild C.P. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiology approach. Mutat. Res. 428 (1999) 187-196
26. Turconi G., Guarcello M., Livieri C., Comizzoli S., Maccarini L., Castellazzi A.M., Pietri A., Piva G., and Roggi C. Evaluation of xenobiotics in human milk and ingestion by the newborn-an epidemiological survey in Lombardy (Northern Italy). Eur. J. Nutr. 43 (2004) 191-197
27. Turner P.C., Mendy M., Whittle H., Fortuin M., Hall A.J., and Wild C.P. Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Trop. Med. Int. Health 5 (2000) 837-841
28. Turner P.C., Moore S.E., Hall A.J., Prentice A.M., and Wild C.P. Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect. 111 (2003) 217-220
29. Turner P.C., Sylla A., Gong Y.Y., Diallo M.S., Sutcliffe A.E., Hall A.J., and Wild C.P. Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study. Lancet 365 (2005) 1950-1956
30. WHO. 2003. Global strategy for infant and young child feeding. Geneva.
31. Wild C.P., and Hall A.J. Primary prevention of hepatocellular carcinoma in developing countries. Mutat. Res. 462 (2000) 381-393
32. Wild C.P., and Kleinjans J. Children and increased susceptibility to environmental carcinogens: evidence or empathy?. Cancer Epidemol. Biomark. Prev. 12 (2003) 1389-1394
33. Wild C.P., and Turner P.C. The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 17 (2002) 471-481
34. Wild C.P., Pionneau F.A., Montesano R., Mutiro C.F., and Chetsanga C.J. Aflatoxin detected in human breast milk by immunoassay. Int. J. Cancer 40 (1987) 328-333
35. Wild C.P., Rasheed F.N., Jawla M.F., Hall A.J., Jansen L.A., and Montesano R. In-utero exposure to aflatoxin in west Africa. Lancet 337 (1991) 1602
36. Wild C.P., Yin F., Turner P.C., Chemin I., Chapot B., Mendy M., Whittle H., Kirk G.D., and Hall A.J. Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia. Int. J. Cancer 86 (2000) 1-7
37. Zarba A., Wild C.P., Hall A.J., Montesano R., Hudson G.J., and Groopman J.D. Aflatoxin M1 in human breast milk from the Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis 13 (1992) 891-894